FIGURE 3.
Changes in the ALBI score after treatment initiation. In non‐e‐PD patients, a significant increase in the ALBI score was observed at 3 weeks after the start of treatment (p < 0.001), remaining roughly the same at 6 weeks (A). Patients with e‐PD also showed a significant increase in the ALBI score in the first 3 weeks of treatment (p < 0.001), and their liver function remained deteriorated at 6 weeks (B).